{"efta_number": "EFTA01896344", "page_count": 1, "url": "https://epstein-data.com/EFTA01896344", "pdf_url": "https://epstein-data.com/pdf/EFTA01896344.pdf", "pages": [{"efta_number": "EFTA01896344", "page_number": 0, "text_content": "Jeffrey Epstein, New York Philanthropist, Funds Pioneering Cancer Metastasis Research at Mount\nSinai Hospital.\nIt is well known that once a tumor metastasizes into the blood stream, the odds of combatting the cancer\ndecline sharply. Surgically removing a pre-metastic tumor however can actually stimulate metastasis. Such\nis often the case with breast cancer. Removal of a pre-metastic tumor is necessary however to avert the\ninevitable spreading of the tumor. So what should a surgeon do?\nIn pivotal new research conducted at Mount Sinai Hospital in New York City, surgeon Dr. Jess Ting,\nbreast oncologist, Dr. Kerin Adelson and molecular biologist, Dr. Doris Germain, are looking at how\nmetastasis is not necessarily intrinsic to the tumor but its environment. The shift in focus is critical explains\nDr. Ting because while extractions should not be averted, the tumor's micro-environment might be changed\nto minimize metastasis from surgery and in general.\nTo obtain a breast tumor's micro-environment, Dr. Ting and his team are using the unique approach of\nstudying fluid emitted from a post-surgery wound site. To date, clinical analysis of a cancer's environment\nhas been the blood, a rich source of disease-related biomarkers. However, blood's complex composition,\namongst other factors, is a major challenge for biomarker assays. Other body fluids, including urine,\ncerebrospina, bronchoalveolar lavage, synovial, amniotic, seminal plasma and interstitial fluids are also\nrich in disease biomarkers. However, these fluids are only informative in advanced metastatic cancer\npatients and so their prognostic value in term of disease progression is limited.\nDr. Ting's team saw that wound fluid (emitted from a draining tube), contains all the proteins, growth\nfactors, cytokines and DNA transcription factors that are secreted by the cells around the cancer and\npresented an ideal way of studying the microenvironment in vivo. Furthermore, wound fluid from a breast\ncancer patient often has the tremendous advantage of having an exact control specimen since the non-\ncancerous breast is often removed as a precaution and wound fluid from that breast can be compared.\nOver the last year, Dr. Ting and his team have found some critical differences between cancerous wound\nfluid and non-cancerous both in test tubes and in mice. As their research continues, they are looking to find\ncommonalities with other cancerous wound fluids, so as to not only identify patients at higher risk of\nmetastasis, but to ultimately to develop a targeted systemic approach to minimize metastasis from\noccurring.\nJeffrey Epstein's foundation, the Jeffrey Epstein VI Foundation, has funded cancer research and cutting edge\nscience all over the world. In 2003, he founded the Program for Evolutionary Dynamics at Harvard University\nwith a $30 million dollar grant. Jeffrey Epstein is a former member of the Trilateral Commission, the Council on\nForeign Relations, the New York Academy of Science and a former board member of Rockefeller University.\nHe is actively involved in the Santa Fe Institute, the Theoretical Biology Initiative at the Institute for Advanced\nStudy in Princeton, the Quantum Gravity Program at the University of Pennsylvania, and also sits on the Mind,\nBrain & Behavior Advisory Committee at Harvard University.\nEFTA_R1_00321184\nEFTA01896344\n", "char_count": 3347}]}